Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 815 |
|
|||||
| News | - | ||||||
| Day High | 2.10 | Low High |
|||||
| Day Low | 2.0201 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pulmatrix Inc | PULM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0051 | 0.25% | 2.0201 | 17:16:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.04 | 2.0201 | 2.10 | 2.0201 | 2.015 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 30 | 815 | $ 2.05 | $ 1,674 | - | 1.55 - 3.14 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:16:10 | 5 | $ 2.10 | USD |
Pulmatrix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.38M | 3.65M | - | 7.3M | -14.12M | -3.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pulmatrix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PULM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.08 | 2.19 | 1.91 | 2.00 | 12,238 | -0.0599 | -2.88% |
| 1 Month | 1.69 | 2.19 | 1.5601 | 1.96 | 20,287 | 0.3301 | 19.53% |
| 3 Months | 1.80 | 2.19 | 1.55 | 1.87 | 16,012 | 0.2201 | 12.23% |
| 6 Months | 1.87 | 2.34 | 1.55 | 1.92 | 15,913 | 0.1501 | 8.03% |
| 1 Year | 2.83 | 3.14 | 1.55 | 2.20 | 14,542 | -0.8099 | -28.62% |
| 3 Years | 0.9706 | 7.50 | 0.2925 | 1.07 | 228,078 | 1.05 | 108.13% |
| 5 Years | 1.08 | 7.50 | 0.2925 | 1.38 | 508,931 | 0.9401 | 87.05% |
Pulmatrix Description
| Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. |
